Linda Maldonado has over 25 years of experience in biologics manufacturing from early clinical phase to commercial operations. Her involvement spans from process development to commercial launch for vaccine, antibody and gene therapy processes and products. Prior to joining Codagenix, she was Senior Director of GMP Manufacturing, Downstream and Fill Finish for Catalent Cell and Gene Therapy (CDMO), where she led early phase production for a wide variety of biologics. Before Catalent, she held positions of increasing responsibility at vaccine and therapeutic manufactures including PharmAthene, Human Genome Sciences, Baxter Bioscience, Progenics and Sanofi Pasteur. Ms. Maldonado has a proven track record with clinical process development, scale-up and technology transfer to GMP production. She has a M.S. in Biology from East Stroudsburg University and a B.S. in Biology from Bloomsburg University.